Volibo R 0.2/1 mg
| SKU | 2606 |
|---|---|
| Generic For | Voglibose R |
| Manufacturer | Ajanta Pharma India |
| Active Ingredient | Voglibose / Repaglinide |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.69 | US$ 20.70 | |||
|
|||||
| 60 Tablet/s | US$ 0.62 | US$ 37.2610%US$ 41.40 | |||
|
|||||
| 90 Tablet/s | US$ 0.59 | US$ 52.7815%US$ 62.10 | |||
|
|||||
Volibo R 0.2/1 mg – Affordable Voglibose R Alternative
Volibo R 0.2/1mg tablet is the combination of two medicines, namely Repaglinide and Voglibose, for treating type 2 diabetes mellitus. The medicine works best when followed with diet, exercise, and weight loss alone have not been able to control our blood sugar.
Type 2 diabetes is a health condition when your pancreas does not make enough insulin to control the sugar available in the blood or where your body does not normally respond to the insulin it produces. Diabetes is a lifelong health condition that affects a patient’s life to some extent. Managing blood sugar is an essential part of diabetes management. Repaglinide reduces blood glucose by stimulating the release of insulin from the pancreas. At the same time, Voglibose helps control the amount of glucose in the blood. Thus both these Medicines (Repaglinide & Voglibose) help reduce the level of blood sugar.
What are the Warning/Precautions?
Volibo R is not recommended in patients with moderate liver disease. Repaglinide should not be consumed if you have severe liver disease. If you have kidney problems, the medicine should be used with caution. In case you have major surgery or have recently suffered a severe illness, an infection, or had an injury. During the times, diabetic control may be lost. The antidiabetic agent is not recommended if you are under 18 or above 75 years of age. Take Volibo R 1 Mg even if you feel well or control your blood sugar level.
What are the Side effects of Volibo R 0.2/1Mg?
- Diarrhea
- Stomach pain
- Hypoglycemia (low blood glucose level)
- Skin rash
- Flatulence
Most of Volibo 1 mg side effects do not require medical attention and gradually resolve over time. However, if the side effects are persistent, talk to your doctor for further advice.
How to Use Volibo R 0.2/1mg tablet?
The recommended starting dose is 0.2/1mg after a meal. Do not stop taking medication as it may put you at risk of serious complications like kidney damage and blindness. Do not chew or break it; swallow the pill with a glass of water. Do not stop taking medicine; your blood sugar may increase and put you at risk of serious complications like kidney damage and blindness if you stop the treatment. Consult with your doctor before doing so. If you take too many tablets, you may have low blood glucose, leading to a hypoglycaemic condition. Please see your doctor understand how to treat this condition.
What is Volibo R 0.2/1 mg and what condition does it treat?
Volibo R 0.2/1 mg is a combination antidiabetic medication containing two active ingredients: voglibose (0.2 mg) and repaglinide (1 mg). This dual-action diabetes medicine is prescribed to help manage type 2 diabetes mellitus in adults. Voglibose belongs to the alpha-glucosidase inhibitor class, while repaglinide is a meglitinide antidiabetic agent. Together, these components work to control elevated blood sugar levels by addressing both post-meal glucose spikes and insulin secretion. This blood sugar control tablet is typically used alongside a balanced diet and exercise program to achieve optimal glycemic management in diabetic patients.
How does Volibo R 0.2/1 mg work to control blood sugar?
Volibo R 0.2/1 mg uses a dual-mechanism approach to regulate blood glucose. The voglibose component slows down carbohydrate digestion in your intestines by inhibiting alpha-glucosidase enzymes, which delays glucose absorption and reduces after-meal blood sugar spikes. Meanwhile, the repaglinide component stimulates your pancreas to release insulin quickly when you eat, helping cells absorb glucose more efficiently. This glucose-lowering combination works synergistically: one ingredient controls how fast sugar enters your bloodstream, while the other ensures adequate insulin response. Together, these antidiabetic actions provide comprehensive postprandial glycemic control throughout the day.
How quickly does Volibo R 0.2/1 mg start working after taking it?
Volibo R 0.2/1 mg begins working within 15 to 30 minutes after ingestion, with the repaglinide component acting particularly fast to stimulate insulin release. The voglibose ingredient starts inhibiting carbohydrate breakdown as soon as food enters your digestive system. Peak blood sugar control typically occurs within one to two hours after taking this diabetes medication. However, achieving stable, long-term glycemic management usually requires several weeks of consistent use combined with dietary modifications. Most patients notice improved post-meal glucose readings within the first few days, but optimal diabetes control develops gradually as your body adjusts to this combination therapy.
When and how should I take Volibo R 0.2/1 mg for best results?
Take Volibo R 0.2/1 mg orally immediately before each main meal, typically two to three times daily. Swallow the tablet whole with water just as you start eating, since the repaglinide component needs food to work safely and the voglibose acts on carbohydrates during digestion. If you skip a meal, skip that dose to avoid hypoglycemia. Never double up if you miss a dose. The timing is crucial for this glucose control medication—taking it without food increases your risk of dangerously low blood sugar. Your healthcare provider will determine your exact dosing schedule based on your meal patterns and blood glucose monitoring results.
Is Volibo R 0.2/1 mg safe for long-term diabetes management?
Volibo R 0.2/1 mg can be used safely for extended periods under proper medical supervision as part of ongoing type 2 diabetes treatment. Both voglibose and repaglinide have established safety profiles for chronic use when prescribed appropriately. Long-term effectiveness depends on regular blood sugar monitoring, periodic liver function tests, and adjusting your treatment plan as needed. Many diabetic patients use this combination antidiabetic medication for years while maintaining good glycemic control. However, individual tolerance varies, and your doctor will assess whether continued use remains appropriate based on your response, any side effects experienced, and overall diabetes management goals.
Can I take Volibo R 0.2/1 mg alongside other medications?
Volibo R 0.2/1 mg may interact with various medications, so inform your healthcare provider about all drugs you're taking. This diabetes medicine can interact with other blood sugar-lowering agents, potentially causing hypoglycemia. Beta-blockers, certain antibiotics, antifungals, and blood thinners may also affect how voglibose and repaglinide work. Some medications may enhance or reduce the glucose-control effects of this combination therapy. Herbal supplements and over-the-counter products should also be discussed. Your pharmacist can check for drug interactions when you fill your prescription at PremiumRxDrugs, ensuring your complete medication regimen works safely together.
How does Volibo R 0.2/1 mg compare to other diabetes medicines?
Volibo R 0.2/1 mg offers unique advantages over single-ingredient diabetes medications by combining two complementary mechanisms in one tablet. Compared to metformin alone, this voglibose-repaglinide combination specifically targets post-meal glucose spikes more effectively. Unlike sulfonylureas that stimulate insulin all day, repaglinide provides meal-specific insulin response, reducing between-meal hypoglycemia risk. The voglibose component adds digestive-level glucose control that DPP-4 inhibitors don't provide. While newer drug classes like SGLT2 inhibitors work through kidney glucose excretion, Volibo R addresses absorption and insulin secretion directly. This dual-action antidiabetic approach makes it particularly suitable for patients with significant postprandial hyperglycemia.
Is generic voglibose-repaglinide as effective as branded Volibo R?
Generic voglibose-repaglinide combinations contain identical active ingredients in the same strengths as branded Volibo R 0.2/1 mg and must meet stringent bioequivalence standards. Regulatory authorities require generics to demonstrate that they deliver the same therapeutic effect, absorption rate, and blood sugar control as brand-name versions. Clinical effectiveness for managing type 2 diabetes remains equivalent whether you choose generic or branded formulations. The primary differences lie in inactive ingredients, packaging, and cost rather than glucose-lowering efficacy. Many patients successfully manage their diabetes with generic alternatives, achieving the same glycemic targets while benefiting from more affordable pricing on this combination antidiabetic therapy.
Why do patients choose PremiumRxDrugs for their Volibo R prescription?
Patients prefer PremiumRxDrugs for Volibo R 0.2/1 mg because of our decade-plus reputation for reliability and authenticity. As a licensed pharmacy, we specialise in delivering manufacturer-sourced voglibose-repaglinide medications at competitive prices, making diabetes management more affordable without compromising quality. Our easy-to-use prescription management system helps you track and reorder your blood sugar tablets on schedule, crucial for consistent glycemic control. Discreet international shipping is available to the USA, UK, Australia, Canada, and beyond, with free shipping options. The combination of genuine antidiabetic medicines, cost savings, privacy, and dependable service provided by PremiumRxDrugs has earned the trust of diabetes patients worldwide seeking convenient access to our essential medications.
What are the common side effects of voglibose and repaglinide?
Common side effects of voglibose and repaglinide include digestive issues such as gas, bloating, abdominal discomfort, and diarrhea, primarily from the voglibose component slowing carbohydrate digestion. The repaglinide ingredient may cause hypoglycemia (low blood sugar), especially if meals are delayed or skipped, with symptoms like dizziness, sweating, shakiness, and hunger. Some patients experience mild nausea or stomach upset when starting this antidiabetic combination. Headaches and upper respiratory symptoms occasionally occur. Most gastrointestinal effects diminish as your body adapts to the medication. Serious reactions are uncommon but require immediate medical attention if you experience severe hypoglycemia or allergic responses.
Who should not take voglibose and repaglinide for diabetes?
Voglibose and repaglinide are not suitable for patients with type 1 diabetes or diabetic ketoacidosis, which require insulin therapy. Those with severe liver disease should avoid this combination since repaglinide is metabolized hepatically. People with inflammatory bowel disease, intestinal obstruction, or severe digestive disorders may have complications from voglibose's effects on carbohydrate absorption. Pregnant or breastfeeding women typically need alternative diabetes treatments. Patients with known hypersensitivity to either active ingredient should not use this medication. Those with severe kidney impairment require careful evaluation before starting this antidiabetic therapy. Always disclose your complete medical history to ensure this glucose-control combination is appropriate for your situation.
Login
Sign Up
Login
Sign Up